Chlamydia vaccine - SIGA
Latest Information Update: 24 Oct 2021
At a glance
- Originator Oregon State University
- Developer Oregon State University; SIGA Technologies
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chlamydial infections
Most Recent Events
- 27 Apr 2005 Discontinued - Preclinical for Chlamydial infections in USA (unspecified route)
- 26 Nov 2004 This vaccine is still in active development
- 16 Aug 2002 This vaccine is still in active development